269 related articles for article (PubMed ID: 34326469)
1. Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach.
Liu Z; Wang A; Pu Y; Li Z; Xue R; Zhang C; Xiang X; E JY; Bu Z; Bai F; Ji J
Oncogene; 2021 Sep; 40(38):5705-5717. PubMed ID: 34326469
[TBL] [Abstract][Full Text] [Related]
2. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing.
Zhang M; Hu S; Min M; Ni Y; Lu Z; Sun X; Wu J; Liu B; Ying X; Liu Y
Gut; 2021 Mar; 70(3):464-475. PubMed ID: 32532891
[TBL] [Abstract][Full Text] [Related]
3. Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach.
Wei J; Ji K; Zhang Y; Zhang J; Wu X; Ji X; Zhou K; Yang X; Lu H; Wang A; Bu Z
Cell Oncol (Dordr); 2024 Apr; 47(2):677-693. PubMed ID: 37943484
[TBL] [Abstract][Full Text] [Related]
4. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
[TBL] [Abstract][Full Text] [Related]
5. Profiling of gastric cancer cell-surface markers to achieve tumour-normal discrimination.
Toh J; Hoppe MM; Thakur T; Yang H; Tan KT; Pang B; Ho S; Roy R; Ho KY; Yeoh KG; Tan P; Sundar R; Jeyasekharan A
BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816956
[TBL] [Abstract][Full Text] [Related]
6. Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.
Maag JLV; Fisher OM; Levert-Mignon A; Kaczorowski DC; Thomas ML; Hussey DJ; Watson DI; Wettstein A; Bobryshev YV; Edwards M; Dinger ME; Lord RV
Mol Cancer Res; 2017 Nov; 15(11):1558-1569. PubMed ID: 28751461
[TBL] [Abstract][Full Text] [Related]
7. HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer.
Chang HR; Nam S; Kook MC; Kim KT; Liu X; Yao H; Jung HR; Lemos R; Seo HH; Park HS; Gim Y; Hong D; Huh I; Kim YW; Tan D; Liu CG; Powis G; Park T; Liang H; Kim YH
Gut; 2016 Jan; 65(1):19-32. PubMed ID: 25410163
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer.
Wu Y; Grabsch H; Ivanova T; Tan IB; Murray J; Ooi CH; Wright AI; West NP; Hutchins GG; Wu J; Lee M; Lee J; Koo JH; Yeoh KG; van Grieken N; Ylstra B; Rha SY; Ajani JA; Cheong JH; Noh SH; Lim KH; Boussioutas A; Lee JS; Tan P
Gut; 2013 Aug; 62(8):1100-11. PubMed ID: 22735568
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach.
Sentani K; Oue N; Sakamoto N; Arihiro K; Aoyagi K; Sasaki H; Yasui W
Mod Pathol; 2008 Apr; 21(4):464-75. PubMed ID: 18204429
[TBL] [Abstract][Full Text] [Related]
10. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
[TBL] [Abstract][Full Text] [Related]
11. Activation of MAT2A-RIP1 signaling axis reprograms monocytes in gastric cancer.
Zhang Y; Yang H; Zhao J; Wan P; Hu Y; Lv K; Hu Y; Yang X; Ma M
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33593829
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma.
Song S; Xu Y; Huo L; Zhao S; Wang R; Li Y; Scott AW; Pizzi MP; Wang Y; Fan Y; Harada K; Jin J; Ma L; Yao X; Shanbhag ND; Gan Q; Roy-Chowdhuri S; Badgwell BD; Wang Z; Wang L; Ajani JA
J Exp Clin Cancer Res; 2021 Jun; 40(1):207. PubMed ID: 34162421
[TBL] [Abstract][Full Text] [Related]
13. Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.
Yin Z; Wu D; Shi J; Wei X; Jin N; Lu X; Ren X
BMC Cancer; 2020 Nov; 20(1):1062. PubMed ID: 33148208
[TBL] [Abstract][Full Text] [Related]
14. Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue.
Heo YJ; Park C; Yu D; Lee J; Kim KM
Sci Rep; 2019 Jul; 9(1):9675. PubMed ID: 31273278
[TBL] [Abstract][Full Text] [Related]
15. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
16. Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathways.
Yang M; Arai E; Takahashi Y; Totsuka H; Chiku S; Taniguchi H; Katai H; Sakamoto H; Yoshida T; Kanai Y
Carcinogenesis; 2020 Nov; 41(11):1473-1484. PubMed ID: 32710740
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis.
Zhang J; Wu Y; Jin HY; Guo S; Dong Z; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Nov; 24(43):4906-4919. PubMed ID: 30487700
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach.
Jiang J; Ding Y; Lu J; Chen Y; Chen Y; Zhao W; Chen W; Kong M; Li C; Teng X; Zhou Q; Xu N; Zhou D; Zhou Z; Wang H; Teng L
Int J Biol Sci; 2022; 18(14):5554-5574. PubMed ID: 36147475
[TBL] [Abstract][Full Text] [Related]
19. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
Kumashiro Y; Yao T; Aishima S; Hirahashi M; Nishiyama K; Yamada T; Takayanagi R; Tsuneyoshi M
Hum Pathol; 2007 Jun; 38(6):857-63. PubMed ID: 17320150
[TBL] [Abstract][Full Text] [Related]
20. Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.
Bain GH; Collie-Duguid E; Murray GI; Gilbert FJ; Denison A; McKiddie F; Ahearn T; Fleming I; Leeds J; Phull P; Park K; Nanthakumaran S; Matula KM; Grabsch HI; Tan P; Welch A; Schweiger L; Dahle-Smith A; Urquhart G; Finegan M; Petty RD
Br J Cancer; 2014 Mar; 110(6):1525-34. PubMed ID: 24569475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
